These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 23083326

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Behavior of knock-in mice with a cocaine-insensitive dopamine transporter after virogenetic restoration of cocaine sensitivity in the striatum.
    O'Neill B, Tilley MR, Han DD, Thirtamara-Rajamani K, Hill ER, Bishop GA, Zhou FM, During MJ, Gu HH.
    Neuropharmacology; 2014 Apr; 79():626-33. PubMed ID: 24412674
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Cocaine reward and locomotion stimulation in mice with reduced dopamine transporter expression.
    Tilley MR, Cagniard B, Zhuang X, Han DD, Tiao N, Gu HH.
    BMC Neurosci; 2007 Jun 21; 8():42. PubMed ID: 17584943
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Dopamine transporter inhibition is required for cocaine-induced stereotypy.
    Tilley MR, Gu HH.
    Neuroreport; 2008 Jul 16; 19(11):1137-40. PubMed ID: 18596615
    [Abstract] [Full Text] [Related]

  • 9. Molecular mechanisms of cocaine reward: combined dopamine and serotonin transporter knockouts eliminate cocaine place preference.
    Sora I, Hall FS, Andrews AM, Itokawa M, Li XF, Wei HB, Wichems C, Lesch KP, Murphy DL, Uhl GR.
    Proc Natl Acad Sci U S A; 2001 Apr 24; 98(9):5300-5. PubMed ID: 11320258
    [Abstract] [Full Text] [Related]

  • 10. Cocaine mechanisms: enhanced cocaine, fluoxetine and nisoxetine place preferences following monoamine transporter deletions.
    Hall FS, Li XF, Sora I, Xu F, Caron M, Lesch KP, Murphy DL, Uhl GR.
    Neuroscience; 2002 Apr 24; 115(1):153-61. PubMed ID: 12401330
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Restoration of cocaine stimulation and reward by reintroducing wild type dopamine transporter in adult knock-in mice with a cocaine-insensitive dopamine transporter.
    Wu H, O'Neill B, Han DD, Thirtamara-Rajamani K, Wang Y, Gu HH.
    Neuropharmacology; 2014 Nov 24; 86():31-7. PubMed ID: 24835281
    [Abstract] [Full Text] [Related]

  • 13. Cocaine reward models: conditioned place preference can be established in dopamine- and in serotonin-transporter knockout mice.
    Sora I, Wichems C, Takahashi N, Li XF, Zeng Z, Revay R, Lesch KP, Murphy DL, Uhl GR.
    Proc Natl Acad Sci U S A; 1998 Jun 23; 95(13):7699-704. PubMed ID: 9636213
    [Abstract] [Full Text] [Related]

  • 14. Characterization of conditioned place preference to cocaine in congenic dopamine transporter knockout female mice.
    Medvedev IO, Gainetdinov RR, Sotnikova TD, Bohn LM, Caron MG, Dykstra LA.
    Psychopharmacology (Berl); 2005 Jul 23; 180(3):408-13. PubMed ID: 15719221
    [Abstract] [Full Text] [Related]

  • 15. Cocaine reward and MPTP toxicity: alteration by regional variant dopamine transporter overexpression.
    Donovan DM, Miner LL, Perry MP, Revay RS, Sharpe LG, Przedborski S, Kostic V, Philpot RM, Kirstein CL, Rothman RB, Schindler CW, Uhl GR.
    Brain Res Mol Brain Res; 1999 Nov 10; 73(1-2):37-49. PubMed ID: 10581396
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Dopamine transporter inhibition is necessary for cocaine-induced increases in dendritic spine density in the nucleus accumbens.
    Martin BJ, Naughton BJ, Thirtamara-Rajamani K, Yoon DJ, Han DD, Devries AC, Gu HH.
    Synapse; 2011 Jun 10; 65(6):490-6. PubMed ID: 20936687
    [Abstract] [Full Text] [Related]

  • 18. SRI-32743, a novel allosteric modulator, attenuates HIV-1 Tat protein-induced inhibition of the dopamine transporter and alleviates the potentiation of cocaine reward in HIV-1 Tat transgenic mice.
    Zhu J, Quizon PM, Wang Y, Adeniran CA, Strauss MJ, Jiménez-Torres AC, Patel P, Cirino TJ, Eans SO, Hammond HR, Deliscar LS, O'Hara P, Saini SK, Ofori E, Vekariya RH, Zhang S, Moukha-Chafiq O, Nguyen TH, Ananthan S, Augelli-Szafran CE, Zhan CG, McLaughlin JP.
    Neuropharmacology; 2022 Dec 01; 220():109239. PubMed ID: 36126727
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.